Venta De Honda Runner Valkyrie 1800 en Espaã±a

Adjunct membership is for researchers employed by other institutions who collaborate with IDM Members to the extent that some of their ain staff and/or postgraduate students may piece of work within the IDM; for 3-year terms, which are renewable.

BARRY III, Dr Clifton
PhD, Section Primary and Senior Investigator, Tuberculosis Research Department (TRS), National Found of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health (NIH).

Areas of interest bridge the bones sciences of chemistry, biochemistry and microbiology, through to pharmacology and clinical medicine, in the areas of mycobacterial pathogenesis and TB drug discovery enquiry.

Dark-brown, Prof Gordon
PhD, FRS, FMedSci, FRSB, FAAM, FRSE, RSSAf, Director MRC Eye for Medical Mycology at the Academy of Exeter and Director of the AFGrica Unit at The University of Cape Town (UCT). Honorary Professor at UCT.

His primary research interests are C-type lectin receptors and their role in homeostasis and immunity, with a particular focus on antifungal amnesty.

Grayness, Prof Clive
Professor Emeritus of Immunology, Partitioning of Immunology, Department of Pathology, University of Cape Town; Professor of Immunology in Molecular Biology and Human Genetics, Stellenbosch Academy, Cape Town; Offshoot Professor, Department of Immunology, Duke University, Northward Carolina, USA; Secretary-General, Federation of African Immunology Societies; Vice-Chair, Education Commission of the IUIS; Director of the Immunopaedia Foundation.

His research interests revolve effectually investigating immune regulation and dysregulation in the context of HIV infection or exposure. He focuses on Immune ontogenesis in HIV exposed infants, placental investigations and pre-term nativity, and epithelial immunity in the foreskin. He has an agile grouping inside the IDM and is based at Stellenbosch University where he directs the Reproductive Immunology Research Consortium in Africa (RIRCA). He is the by Chair of Immunology at UCT and holder of several NIH and European-based grants.

GRAY, Prof Glenda
MBBCH, FCP (Paeds) SA. Executive Director Perinatal HIV Research Unit of measurement, Wits Wellness Consortium, University of Witwatersrand; Associate Professor, Department of Paediatrics, University of Witwatersrand, Southward Africa; HVTN Manager of International Programmes; HVTN Co-Principal Investigator; Chair of the standing commission on Health, ASSAF.

Her Enquiry Unit is involved with clinical inquiry, epidemiology and operational research, and is a handling site for HIV infected adults and children. Her enquiry interests include HIV vaccine inquiry, microbicide inquiry and other biomedical and behavioural interventions, and she is an investigator in testing two HIV vaccine regimens in late phase clinical development. Her TB research includes examining new agents to forbid TB, TB prophylaxis and TB vaccine evaluation.

GROBUSCH, Prof Martin
Professor, Dr. Med. (M.D.), PhD, M.Sc. (Lond), DTM&H (Lond), FRCP (Lond). Specialist in Internal Medicine, Infectious Diseases, Tropical Medicine. Full Professor and Chair of Tropical Medicine and Travel Medicine and Head, Center of Tropical Medicine and Travel Medicine, Amsterdam Medical Centre, University of Amsterdam in the netherlands.

He has been an author on over 150 manuscripts in the field of infectious diseases and has an extensive runway tape in infectious diseases research and practice covering clinical, laboratory and epidemiological aspects.

LESLIE, Dr Al
Primary investigator Africa Health Research Constitute (AHRI), Durban, Due south Africa; Associate Professor, University of KwaZulu Natal, Durban, South Africa; Wellcome Trust senior Fellow, department of infection and immunity, University College London, UK.

He is an HIV and TB immunologist focused on studying the immune response to these pathogens in affected tissues, and how this relates to what can be observed from the blood. The inquiry goal is to ameliorate understanding of the immunopathology of TB and HIV, using this data to assist in developing novel therapeutic approaches and diagnostic biomarkers.

LEWINSOHN , Prof Dave

Dr., PhD, Professor and Vice Chair for Research, Department of Medicine, Managing director OHSU Eye for Global Child Health Research, Section of Pediatrics.

His research has centered on understanding the mechanisms by which the man immune organisation recognises the Mycobacterium tuberculosis (M.tb) infected prison cell. This enquiry has focused largely on CD8+ T cells, with a focus on both those antigens that are recognised, and the ways by which they are presented. His work has a strong translational component, asking if both classically and non-classically restricted T cells are associated with infection with Thousand. tb, reflect immunological retentivity, and are enriched at the site of infection.

LEWINSOHN, Prof Deborah

MD, Professor, and Vice Chair for Enquiry, Division Head Infectious disease, Wayne 50. Tracy Professor of Communicable diseases, Department of Pediatrics, Banana Director, OHSU Center for Global Child Health Research.

Her research focuses on understanding the function of the developing immune system on the susceptibility of young children to tuberculosis (TB) and understanding the part of innate and adaptively acquired CD8+ T cells in host defense to TB. The translational significance of this research is centred on informing the development of novel vaccines and diagnostics for childhood TB.

MOORE, A/Prof Penny
South African Inquiry Chair in Viral Host Dynamics, Faculty of Wellness Sciences, University of Witwatersrand and National Found for Communicable Diseases.

Her current research focuses on HIV broadly neutralising antibodies and their coaction with the evolving virus. Recent studies published in PloS Pathogens, Nature and Nature Medicine have highlighted the role of viral escape in creating new epitopes and immunotypes, thereby driving the development of neutralisation breadth, with implications for HIV vaccine design.

NICOL, Prof Mark
Schoolhouse of Biomedical Sciences, Division of Infection and Immunity, Academy of Western Australia; Professor in Microbiology.

Research interest in tuberculosis and in developing and testing bespeak of care diagnostics suitable for the developing world.

REDD, Dr Andrew
PhD, Staff Scientist in International HIV and STD Section, National Institute of Allergy and Infectious Diseases at the The states National Institutes of Health; Banana Professor of Medicine at Johns Hopkins University.

His research is focused on better agreement HIV manual and disease dynamics with a special concentration on HIV superinfection, latent HIV infection, and the role of the virus in HIV+ organ transplantation.

WILKINSON, A/Prof Katalin
Chief Research Scientist at The Francis Crick Institute London; Honorary Associate Professor, Division of Infection and Amnesty, University Higher London; Honorary Associate Professor, Section of Medicine, University of Cape Boondocks.

Her inquiry focuses on the immunology of HIV-associated tuberculosis (TB). More than specifically, the reconstitution of the immune response during antiretroviral treatment, in order to identify correlates of protection (including immune mechanisms that lead to reduced susceptibility to TB), and pathogenesis (such as the Tuberculosis-Associated Allowed Reconstitution Inflammatory Syndrome, TB-IRIS); the biosignature of the TB infection spectrum, from latent infection to active disease; preventing TB infection in HIV infected people more effectively; and the pathogenesis of tuberculous meningitis and pericarditis.